The effect of thiol functional group incorporation into cationic helical peptides on antimicrobial activities and spectra.

Antimicrobial peptides (AMP) have been proposed as blueprints for the development of new antimicrobial agents for the treatment of drug resistant infections. A series of synthetic AMPs capable of forming α-helical structures and containing free-sulfhydryl groups are designed in this study ((LLKK)(2)C, C(LLKK)(2)C, (LLKK)(3)C, C(LLKK)(3)C). In particular, the AMP with 2 cysteine residues at the terminal ends of the peptide and 2 repeat units of LLKK, i.e., C(LLKK)(2)C, has been demonstrated to have high selectivity towards a wide range of microbes from Gram-positive Bacillus subtilis, Gram-negative Escherichia coli, Pseudomonas aerogenosa, and yeast Candida albicans over red blood cells. At the MIC levels, this peptide does not induce significant hemolysis, and its MIC values occur at the concentration of more than 10 times of their corresponding 50% hemolysis concentrations (HC(50)). Microscopy studies suggest that this peptide kills microbial cells by inducing pores of ∼20-30 nm in size in microbial membrane on a short time scale, which further develops to grossly damaged membrane envelope on a longer time scale. Multiple treatments of microbes with this peptide at sub MIC concentration do not induce resistance, even up to passage 10. However, the same treatment with conventional antibiotics penicillin G or ciprofloxacin easily develop resistance in the treated microbes. In addition, the peptides are shown not to induce secretion of IFN-γ and TNF-α in human monocytes as compared to lipopolysaccharide, which implies additional safety aspects of the peptides to be used as both systemic and topical antimicrobial agents. Therefore, this study provides an excellent basis to develop promising antimicrobial agents that possess a broad range of antimicrobial activities with less susceptibility for development of drug resistance.

[1]  P. Y. Chou,et al.  Empirical predictions of protein conformation. , 1978, Annual review of biochemistry.

[2]  Yi Yan Yang,et al.  Biomimetic hydrogels for chondrogenic differentiation of human mesenchymal stem cells to neocartilage. , 2010, Biomaterials.

[3]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[4]  Y. Carmeli,et al.  Antibacterial Properties of Dermaseptin S4 Derivatives with In Vivo Activity , 2002, Antimicrobial Agents and Chemotherapy.

[5]  B. Wachowicz,et al.  Effects of Lipopolysaccharides from Gram-Negative Bacteria on the Level of Thiols in Blood Platelets , 2005, Current Microbiology.

[6]  Rein V. Ulijn,et al.  Peptide-based stimuli-responsive biomaterials. , 2006, Soft matter.

[7]  H. Schweizer,et al.  Bacterial resistance to antibiotics: active efflux and reduced uptake. , 2005, Advanced drug delivery reviews.

[8]  Yihua Loo,et al.  Natural tri- to hexapeptides self-assemble in water to amyloid β-type fiber aggregates by unexpected α-helical intermediate structures , 2011, Proceedings of the National Academy of Sciences.

[9]  Gregory Stephanopoulos,et al.  A linguistic model for the rational design of antimicrobial peptides , 2006, Nature.

[10]  Lanjuan Li,et al.  The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. , 2010, Biomaterials.

[11]  P. Lambert.  Bacterial resistance to antibiotics: modified target sites. , 2005, Advanced drug delivery reviews.

[12]  Gerard D. Wright,et al.  Bacterial resistance to antibiotics: enzymatic degradation and modification. , 2005, Advanced drug delivery reviews.

[13]  J. Lu,et al.  Molecular self-assembly and applications of designer peptide amphiphiles. , 2010, Chemical Society reviews.

[14]  I. Nagaoka,et al.  Involvement of cysteine residues in the biological activity of the active fragments of guinea pig neutrophil cationic peptides , 1995, Infection and immunity.

[15]  G. Bell,et al.  Arming the enemy: the evolution of resistance to self-proteins. , 2003, Microbiology.

[16]  J. Lu,et al.  Antibacterial activities of short designer peptides: a link between propensity for nanostructuring and capacity for membrane destabilization. , 2010, Biomacromolecules.

[17]  Bing Xu,et al.  Controlling self-assembly within nanospace for peptidenanoparticle fabrication. , 2008, Soft matter.

[18]  Y. Tong,et al.  Self‐assembled Cationic Peptide Nanoparticles Capable of Inducing Efficient Gene Expression In Vitro , 2008 .

[19]  David F. Williams.  On the mechanisms of biocompatibility. , 2008, Biomaterials.

[20]  Aqeel Ahmad,et al.  Cell-selective lysis by novel analogues of melittin against human red blood cells and Escherichia coli. , 2010, Biochemistry.

[21]  Weimin Fan,et al.  Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. , 2009, Nature nanotechnology.

[22]  Michael W Parker,et al.  Structure of a Cholesterol-Binding, Thiol-Activated Cytolysin and a Model of Its Membrane Form , 1997, Cell.

[23]  E. Kenawy,et al.  Biologically active polymers: VII. Synthesis and antimicrobial activity of some crosslinked copolymers with quaternary ammonium and phosphonium groups , 2006 .

[24]  B. Kos,et al.  Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects. , 2008 .

[25]  Ian W. Hamley,et al.  Self-assembly of amphiphilic peptides , 2011 .

[26]  Shuguang Zhang,et al.  Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents. , 2011, Biomaterials.

[27]  H. Vogel,et al.  Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.

[28]  B A Cunha,et al.  Enhancement of bismuth antibacterial activity with lipophilic thiol chelators , 1997, Antimicrobial agents and chemotherapy.

[29]  R. J. Doerksen,et al.  De novo design of biomimetic antimicrobial polymers , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[31]  Yen Wah Tong,et al.  Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. , 2009, Biomaterials.

[32]  B. Applegate,et al.  Synergistic activity of hydrophilic modification in antibiotic polymers. , 2007, Biomacromolecules.

[33]  Y. Tong,et al.  Enzymatically crosslinked collagen-mimetic dendrimers that promote integrin-targeted cell adhesion. , 2008, Biomaterials.

[34]  R. Hancock,et al.  Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. , 2002, Current drug targets. Infectious disorders.